Brief: Biolidics Says Accelerate Grants C0 Right To Use Tech For Detection Of COVID-19 Viral Spike/Angiotensin Converting Enzyme 2 Blocking Antibodies

Embracing Future Holdings

14/07/2020 15:53

July 14 (Reuters) - Biolidics Ltd  BIOL.SI :
    * ACCELERATE GRANTED COMPANY NON-EXCLUSIVE WORLDWIDE RIGHTS
TO
MARKET SEROLOGY TESTS WHICH INCORPORATE TECHNOLOGY
    * ON 9 JULY 2020, ENTERED INTO LICENSING AGREEMENT WITH
ACCELERATE
TECHNOLOGIES PTE LTD
    * ACCELERATE GRANTS CO RIGHTS TO USE TECHNOLOGY FOR
DETECTION OF
COVID-19 VIRAL SPIKE/ANGIOTENSIN CONVERTING ENZYME 2 BLOCKING
ANTIBODIES

Source text for Eikon:  urn:newsml:reuters.com:*:nSNZb6C4Rp
Further company coverage:  BIOL.SI 

 ((Reuters.Briefs@thomsonreuters.com;))